Related to GVK and Excel PharmaStudies Join Forces to Help Sponsors Conduct Clinical Trials in India and China

• Thermo Fisher Scientific Collaborates to Advance Biomarker Research in Japan
  
• PPD Bolsters Presence in Russia by Opening a New Office
  
• ISCO and Insight Bioventures Sets Up Indian Affiliate
  
• Sinovac Wins $1.8M Chinese Flu Vaccine Contract and Gets Anflu Sanctioned in Hong Kong
  
• Nycomed Takes Majority Stake in Chinese Pharma Firm Techpool Bio-Pharma
  
• AB Sciex Bolsters Presence in Korea
  
• Protein Sciences Expands Flu Vaccine Candidate License Arrangement with UMN
  
• Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M
  
• SuperNova Inks Deal with KSB to Expand Diagnostic Business into China
  
• Novartis Completes $125M Acquisition of Majority Stake in Chinese Vaccines Firm
  
• Quest Diagnostics to Launch Vermillion's Ovarian Cancer Test in India
  
• EMD Millipore Opens Shanghai Biopharmaceutical Technical Center
  
• Nycomed to Market Roche’s Osteoporosis Treatment in Asia Pacific
  
• Merck Serono Opens Biomarker R&D Lab at Pharmaron’s Facility in Beijing
  
• Covidien Plans Shanghai R&D Center as Flagship of China Research Operations
  
• Evotec Takes Over Full Ownership of JV in India for €1.7M
  
• AKP Pays Zosano $7.5M as Part of Asian Agreement for Transdermal Parathyroid Hormone Patch
  
• Rosetta Genomics to Slash 35 Jobs to Focus on MDx Commercialization in the U.S.
  
• WuXi Takes Over Antibody and Research Reagents Firm Abgent
  
• ShangPharma Snaps Up Charles River Facility in Shanghai